A brief overview of GLP-1 RA's and their role in DM2 therapy.
Some take-away points from the ACCOMPLISH Trial
A quick review of the evidence-based beta-blockers that are used in HFrEF.
Entresto - A review of the ARNI approved for the treatment of HFrEF.
Just a quick overview of the new subcutaneous version of buprenorphine that is administered only once monthly.
A quick discussion about the potential harms of atenolol when used for the treatment of hypertension.
I review the results of the DARE Trial and provide a strategy for helping patients with diabetes see the importance of exercise.
A very quick review of the RALES trial. RALES looked at spironolactone use in patients with HFrEF.
This is a brief discussion of the Remicade biosimilars that have been approved. I also discuss the FDA's Purple Book.
A brief discussion on using letermovir as prophylaxis against CMV in patients that have undergone hematopoietic stem cell transplantation.